Navigation Links
Generex Touts Pipeline Potential of Antigen Express Subsidiary
Date:2/7/2013

y (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One focuses on modification of peptides with Ii-Key to increase potency while a second relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Cautionary Note Regarding Forward-Looking Statements

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual r
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
2. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
3. Generex Augments Antigen Express Scientific Advisory Board
4. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
5. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
6. Generex Announces Results of Annual Stockholders Meeting
7. Generex Addresses Recent Trading Volume in Shares of its Common Stock
8. Generex Announces Details of Investor Conference Call
9. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
10. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
11. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... N.C. , June 1, 2015  bioMérieux, a ... diagnostics, has been invited to join the White ... antibiotic use in the U.S. as a means to ... sectors, will gather tomorrow, June 2, 2015, to discuss ... five years to slow the emergence of antibiotic-resistant bacteria, ...
(Date:6/1/2015)... , June 1, 2015 The Middle Eastern ... diagnostic tool which is replacing CT because of its higher ... more popular one between the two available systems of MRI, ... in the top and bottom and do not enclose the ... There is a study which shows that one in every ...
(Date:6/1/2015)... , June 1, 2015 NEOVIA ONCOLOGY ... engaged in the development and commercialization of novel, ... it has met with the U.S. Food and ... filing of an Investigational New Drug (IND) application ... a result of the meeting, Neovia has clarified ...
Breaking Medicine Technology:bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Middle East Open System MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2Neovia Oncology Announces First IND Meeting 2
... 2010 Sequenom, Inc. (Nasdaq: SQNM ) ... Sequenom Center for Molecular Medicine (Sequenom CMM), has authorized ... study is designed to evaluate the clinical performance of ... detection of an overabundance in maternal blood of chromosome ...
... 22, 2010 Renal Advantage and Liberty Dialysis, which last ... of dialysis services in the U.S., today announced that they ... were not disclosed – was completed on December 17, 2010. ... patients in 260 locations in 32 states. "The ...
Cached Medicine Technology:Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 2Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 3Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 4Renal Advantage and Liberty Dialysis Deal Completed 2Renal Advantage and Liberty Dialysis Deal Completed 3
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Marcy Herrmann as a 2015-2016 inductee into ... recognized with this prestigious distinction for leadership in life ... for professional women, boasting more than 700,000 members and ... to present Marcy with this distinction,” said NAPW President ...
(Date:6/1/2015)... 02, 2015 The National Association ... a 2015-2016 inductee into its VIP Woman of ... prestigious distinction for leadership in business. NAPW is ... women, boasting more than 700,000 members and over ... welcome Kathy into this exceptional group of professional ...
(Date:6/1/2015)... Carson Energy also announced they have selected ... AdvantaIRA Trust, LLC is the country’s largest self-directed IRA ... positions using IRA’s does 2 things:, 1. It gives ... if there current cash position will not allow for ... Carson and their investors to be able to participate ...
(Date:6/1/2015)... LONE TREE, CO (PRWEB) June 01, 2015 ... to announce they have been named an Ultherapy® ... Ultherapy. Atagi Plastic Surgery and Skin Aesthetics is one ... by Ulthera as a premier treatment provider. , ... with Ultherapy in the Denver area has led the ...
(Date:6/1/2015)... 2015 On May 14, 2015, the ... hosted the Cherry Creek Chamber of Commerce for the ... care centers typically do not offer primary care services ... Cherry Creek Urgent Care staff to schedule family care ... 5:30 to 7:30 p.m. the center hosted presidents, CEOs, ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Marcy Herrmann, Therapist, Life Coach, Advanced Handwriting Analyst, Into its VIP Professional Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Atagi Plastic Surgery and Skin Aesthetics Named Ultherapy® Ultra Treatment Provider 2Health News:Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic 2
... who are diagnosed with prostate cancer by biopsy are more ... aggressive// case of the disease than the biopsy results would ... Medical Center researcher. ,The finding suggests that misleading ... to receive inadequate or inappropriate treatment that is not aggressive ...
... new blood thinner, one of the first signs the drug ... bleeds and bruising,// an inconvenient side effect of preventing the ... and stroke. While potentially life-saving, the drugs can also pose ... monitoring of blood levels. ,So when he didn’t ...
... disabled? Can parents arrange surgical interventions on their children, hoping life ... a raised in a beated debate in the US. ... stopped developing when she was only three months old. ... recognize her family members and to enjoy music. But she can ...
... news. His colon cancer, which was treated two years ... with chemotherapy in 2005 after doctors removed his colon in ... metastatic. Yet after recent surgery to remove a growth ... liver. ,Though patients often can be cured of ...
... pill to control high blood pressure and new drugs ... Clinic researchers have designed two promising new cardiovascular treatment ... pill form to lower high blood pressure and a ... kidney function. ,In the process, they ...
... children, yet the number of pediatric orthopedists trained to ... decreasing nationwide. The management of fractures in children is ... is needed to provide the best care for these ... for Special Surgery (HSS). ,Fractures in ...
Cached Medicine News:Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 2Health News:Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men 3Health News:New Blood Thinner May Work Without Bleeding Risk 2Health News:Debate in US: Who Should Decide for Disabled People? 2Health News:White House Press Secretary to Battle Second Round of Colon Cancer 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 2Health News:Hormone-based Heart Pill to Control High Blood Pressure 3Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 2Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 3
Idophor PVP Scrub Winged Sponges...
Triad Plus PVP-I Scrub Winged Sponges...
... preoperative skin preparation an ... site infections. Scrub Care brand ... offer high efficacy and safety ... Prevail-Fx offers the highest level ...
Single-dose applicator. Provides a superior, hands-off "friction scrub," enhancing the efficacy of the antiseptic solution it delivers....
Medicine Products: